14th Apr 2015 08:58
LONDON (Alliance News) - Cambridge Cognition Holdings PLC on Tuesday said sales of the Cantab Connect CTIS-Abuse Liability product on the Apple iPad have exceeded GBP1 million in the nine months since launch.
The product is a cloud-based platform designed for the clinical assessment of a medication's potential for abuse.
"The immediate impact of Cantab Connect CTIS-AL shows there is a clear market need for enhanced assessment products and reinforces our decision to focus on clinical trials that deal with Human Abuse Liability, drug characterisation and safety," said Chief Executive Nick Kerton.
"We expect to build on this rapid market acceptance as we continue to extend our portfolio of Cantab Connect products for cognitive assessments in clinical trials," Kerton added.
Shares in the company were up 2.5% to 84.03 pence on Tuesday morning.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Cambridge Cog